These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 37369954)
21. The lncRNA NEAT1/miR-29b/Atg9a axis regulates IGFBPrP1-induced autophagy and activation of mouse hepatic stellate cells. Kong Y; Huang T; Zhang H; Zhang Q; Ren J; Guo X; Fan H; Liu L Life Sci; 2019 Nov; 237():116902. PubMed ID: 31610195 [TBL] [Abstract][Full Text] [Related]
22. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β. Chen X; Zhu S; Chen SY; Wang JN; Sun LJ; Tao SM; Li XF; Li HD; Sun YY; Xu CH; Suo XG; Ji ML; Huang C; Meng XM; Li J Int Immunopharmacol; 2022 Sep; 110():109034. PubMed ID: 35834952 [TBL] [Abstract][Full Text] [Related]
23. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a. Yu F; Fan X; Chen B; Dong P; Zheng J Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641 [TBL] [Abstract][Full Text] [Related]
24. Liver microRNA-29b-3p positively correlates with relative enhancement values of magnetic resonance imaging and represses liver fibrosis. Gong X; Wang X; Zhou F J Biochem; 2020 Dec; 168(6):603-609. PubMed ID: 32653922 [TBL] [Abstract][Full Text] [Related]
25. miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7. Yu K; Li N; Cheng Q; Zheng J; Zhu M; Bao S; Chen M; Shi G J Mol Med (Berl); 2018 Jan; 96(1):65-74. PubMed ID: 29051972 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3. Li H; Zhang L; Cai N; Zhang B; Sun S Ann Hepatol; 2021; 23():100305. PubMed ID: 33434689 [TBL] [Abstract][Full Text] [Related]
29. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway. Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152 [TBL] [Abstract][Full Text] [Related]
30. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. You H; Wang L; Bu F; Meng H; Pan X; Li J; Zhang Y; Wang A; Yin N; Huang C; Li J FASEB J; 2021 Jul; 35(7):e21700. PubMed ID: 34105828 [TBL] [Abstract][Full Text] [Related]
31. miR-199a-3p is involved in estrogen-mediated autophagy through the IGF-1/mTOR pathway in osteocyte-like MLO-Y4 cells. Fu J; Hao L; Tian Y; Liu Y; Gu Y; Wu J J Cell Physiol; 2018 Mar; 233(3):2292-2303. PubMed ID: 28708244 [TBL] [Abstract][Full Text] [Related]
32. miR-222 overexpression may contribute to liver fibrosis in biliary atresia by targeting PPP2R2A. Dong R; Zheng Y; Chen G; Zhao R; Zhou Z; Zheng S J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):84-90. PubMed ID: 25238119 [TBL] [Abstract][Full Text] [Related]
33. MiR-142-3p blocks TGF-β-induced activation of hepatic stellate cells through targeting TGFβRI. Yang X; Dan X; Men R; Ma L; Wen M; Peng Y; Yang L Life Sci; 2017 Oct; 187():22-30. PubMed ID: 28823564 [TBL] [Abstract][Full Text] [Related]
34. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis. Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418 [TBL] [Abstract][Full Text] [Related]
35. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver. Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586 [TBL] [Abstract][Full Text] [Related]
36. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2. Yu F; Chen B; Fan X; Li G; Dong P; Zheng J Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595 [TBL] [Abstract][Full Text] [Related]
37. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes. Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572 [TBL] [Abstract][Full Text] [Related]
38. Identification lncRNA LOC102551149/miR-23a-5p pathway in hepatic fibrosis. Dong Z; Li S; Si L; Ma R; Bao L; Bo A Eur J Clin Invest; 2020 Jun; 50(6):e13243. PubMed ID: 32306379 [TBL] [Abstract][Full Text] [Related]
39. MiR-22-3p and miR-29a-3p synergistically inhibit hepatic stellate cell activation by targeting AKT3. Wang Y; Zhang R; Li J; Han X; Lu H; Su J; Liu Y; Tian X; Wang M; Xiong Y; Lan T; Zhang G; Liu Z Exp Biol Med (Maywood); 2022 Oct; 247(19):1712-1731. PubMed ID: 35833537 [TBL] [Abstract][Full Text] [Related]
40. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2. Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]